| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 6 | |
| #2 | United States | 3 | |
| #3 | Australia | 2 | |
| #4 | Canada | 2 | |
| #5 | WIPO (World Intellectual Property Organization) | 2 | |
| #6 | China | 1 | |
| #7 | Israel | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Therapeutic chemical compounds | |
| #3 | Medical preparations |
| # | Name | Total Patents |
|---|---|---|
| #1 | Mueller-Hermelink Hans Konrad | 12 |
| #2 | Vollmers Heinz Peter | 11 |
| #3 | Hensel Frank | 10 |
| #4 | Vollmers Heinz | 3 |
| #5 | Muller-Hermelink Hans Konrad | 3 |
| #6 | Buechner-Vollmers Annette | 2 |
| #7 | Heinz Vollmers | 1 |
| #8 | Frank Hensel | 1 |
| #9 | Konrad Muller-Hermelink Hans | 1 |
| Publication | Filing date | Title |
|---|---|---|
| CA2553826A1 | Neoplasm-specific polypeptides and their uses | |
| AU2002325164B2 | Receptor, the use thereof, and mouse antibodies | |
| US7767787B1 | Substance for obtaining highly effective tumor medications as well as a process |